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Abstract
Background: The potentials of the leaves of the haemorrhage plant, Aspilia africana C. D Adams
(Compositae) in wound care was evaluated using experimental models. A. africana, which is
widespread in Africa, is used in traditional medicine to stop bleeding from wounds, clean the
surfaces of sores, in the treatment of rheumatic pains, bee and scorpion stings and for removal of
opacities and foreign bodies from the eyes. The present study was undertaken to evaluate the
potentials for use of leaves of this plant in wound care.
Methods: The effect of the methanol extract (ME) and the hexane (HF) and methanol (MF)
fractions (obtained by cold maceration and graded solvent extraction respectively) on bleeding/
clotting time of fresh experimentally-induced wounds in rats, coagulation time of whole rat blood,
growth of microbial wound contaminants and rate of healing of experimentally-induced wounds in
rats were studied as well as the acute toxicity and lethality (LD50) of the methanol extract and
phytochemical analysis of the extract and fractions.
Results: The extract and fractions significantly (P < 0.05) reduced bleeding/clotting time in rats and
decreased coagulation time of whole rat blood in order of magnitude of effect: MF>ME>HF. Also,
the extract and fractions caused varying degrees of inhibition of the growth of clinical isolates of
Pseudomonas fluorescens and Staphylococcus aureus, as well as typed strains of Ps. aeruginosa (ATCC
10145) and Staph. aureus (ATCC 12600), and reduced epithelialisation period of wounds
experimentally-induced in rats. Acute toxicity and lethality (LD50) test in mice established an i.p
LD50 of 894 mg/kg for the methanol extract (ME). Phytochemical analysis revealed the presence of
alkaloids, saponins, tannins, flavonoids, resins, sterols, terpenoids and carbohydrates.
Conclusion: The leaves of A. africana possess constituents capable of arresting wound bleeding,
inhibiting the growth of microbial wound contaminants and accelerating wound healing which
suggest good potentials for use in wound care.
Background
Wounds occur when the continuity of the skin or mucous
membrane is broken [1]. Injury to tissues results in bleed-
ing (which may be life-threatening depending on the
severity) with subsequent activation of acute inflamma-
tory reactions. Bleeding from damaged blood vessels in
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the injured tissue must be arrested through the process of
haemostasis. The injury and associated acute inflamma-
tory response result to necrosis of specialized cells and
damage to the surrounding matrix [2] and the host tissues
must activate the healing process to replace dead tissues
with healthy ones. However, microbial infection of the
wound impairs the healing process [2] and may delay tis-
sue repair. Besides the pain and general discomfort arising
from injuries or wounds there may be alteration of func-
tion which interferes with the individual's ability to carry
on with daily life activities. Consequently, there is an
overriding need to stimulate healing and restore the nor-
mal functions of the affected part(s) of the body to ease
the discomfort and pain associated with wounds by arrest-
ing bleeding from fresh wounds, preventing infection,
and activating tissue repair processes.
Several medicinal plants are used in folklore for wound
treatment. One of such plants is Aspilia africana C.D.
Adams (Compositae), a herb about 1 m tall covered with
bristles [3] and commonly known as "haemorrhage
plant" due to its ability to stop bleeding from fresh
wounds [4]. In Nigeria, it is variously known as
"Orangila" in Igbo, "Tozalin" in Hausa, "Yunyun" in
Yoruba and "Edemedong" in Efik [5] and widespread in
Africa [6]. The morphological features have been fully
described [3,6]. In wound care in herbal medicine, the
bruised leaves and flowers of A. africana are used to clean
the surfaces of sores [5] with subsequent healing [7]. In
addition, it is also used for the treatment of rheumatic
pains [4] as well as bee and scorpion stings [5]. The decoc-
tion has been used to remove corneal opacities and for-
eign bodies from the eyes [5]. The haemostatic [8],
antibacterial [9], membrane stabilization [10] and anti-
inflammatory [11] activities of A. africana have been
reported. The leaf extract has also been shown to cause
extracellular Ca2+  dependent increase in vascular tone
[12]. The isolation of a number of terpenoids from the
leaves of A. Africana has been documented. Sesquiterpe-
nes and monoterpenes were isolated from the essential oil
of the leaves [13]. Germacrene D was reported as the
major sesquiterpene while α-pinene and limonene were
the major monoterpenes [13]. A comparative phytochem-
ical analysis of the leaves of A. africana has identified
saponins and tannins as the most abundant constituents
of the plant [14].
The ethnomedicinal uses of this plant suggest its useful-
ness in wound treatment and stimulated our interest to




Fresh leaves of A. africana were collected in October 2003
within the premises of University of Nigeria, Nsukka and
authenticated by Mr. A. Ozioko of the Bioresources Devel-
opment and Conservation Program (BDCP) Center, Nsu-
kka, Enugu State, Nigeria where a voucher specimen
(BDCP 206) is maintained. The leaves were cut into
smaller pieces, dried under the sun for 2 days and pulver-
ized to powder using a hand blender.
The leaf powder (250 g) was extracted with methanol by
cold maceration for 48 h to obtain the methanol extract
(ME). A fresh batch of leaf powder (500 g) was succes-
sively extracted with n-hexane and methanol to obtain the
n-hexane (HF) and methanol fractions (MF). The extract
and fractions were concentrated in a rotary evaporator
under reduced pressure to afford 10.2 g of methanol
extract (ME), 2.1 g of n-hexane fraction (HF) and 17.8 g of
methanol fraction (MF). The extract and fractions were
subjected to phytochemical analysis for identification of
constituents using standard methods [15].
Pharmacological tests
Animals
Adult Swiss albino mice and rats and guinea pig of both
sexes were obtained from the laboratory animal facility of
the Department of Pharmacology & Toxicology, Faculty of
Pharmaceutical Sciences, University of Nigeria, Nsukka.
The animals were housed in groups in cages within the
facility and maintained freely on standard pellets and
water. They were allowed to acclimatize to the work area
environment for two weeks prior to use. All animal exper-
iments were in compliance with the National Institute of
Health Guide for Care and Use of Laboratory Animal (Pub
No. 85-23, revised 1985).
Acute toxicity and lethality (LD50) test
The acute toxicity and lethality (LD50) of the methanol
extract (ME) was determined in mice using the method of
Lorke [16]. Animals in groups of three received one of 10,
100, or 1000 mg/kg of ME suspended in 3% v/v Tween 85
administered intraperitoneally and observed for 24 h for
number of deaths. From the results of the first test, 200,
400, 800, and 1600 mg/kg doses of the extract were
administered to a fresh batch of animals at one animal per
dose and the number of deaths in 24 h recorded. The LD50
was calculated as the geometric mean of the highest non-
lethal dose (800 mg/kg) and the lowest lethal dose (1000
mg/kg).
Bleeding/clotting time test
The effect of the extract and fractions on bleeding from
fresh experimentally-induced wounds was evaluated
using the bleeding/clotting time test in rats. Briefly, adultBMC Complementary and Alternative Medicine 2007, 7:24 http://www.biomedcentral.com/1472-6882/7/24
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albino rats (200–250 g) of both sexes were divided into
five groups of three animals each. Each group received one
of the ME, HF or MF suspended in 3% v/v Tween 85. Con-
trol animals received either the vehicle or normal saline.
The tail of each rat was cut with a sharp pair of scissors.
Immediately, a drop of the extract/fraction (100 μg/ml)
was placed on the cut and at the same time a stopwatch
was started. The cut was dabbed with a small piece of filter
paper every 15 s until the paper no longer stained red with
blood oozing from the cut. Bleeding time was taken as the
time for the first drop of blood to show to the time when
the filter paper stopped showing bloodstain [17].
Coagulation time of whole blood
The effect of the extract and fractions on coagulation of
fresh blood was evaluated using the coagulation time of
whole rat blood. Adult albino rats (200–250 g) of both
sexes were divided into 8 groups of three animals each.
Each animal was anaesthetized with chloroform and the
thoracic cavity opened to expose the aorta. The aorta was
severed and 1 ml of blood withdrawn using a plastic dis-
posable syringe. The blood was quickly delivered into
clean paraffin-coated glass tubes (10 mm diameter) con-
taining 0.5 ml of one of the ME, HF or MF (10, 100 ug/ml)
suspended in 3% v/v Tween 85. The vehicle or normal
saline was used as the control. The glass tubes were
swirled every 15 s to check the fluidity of the contents. The
interval between the introduction of the blood and the
time of clot formation was taken as the coagulation time
[17].
Antimicrobial activity test
The effect of extract and fractions on microbial wound
contaminants was evaluated using the antimicrobial activ-
ity on wound isolates. Clinical wound isolates were col-
lected in sterile swab sticks from patients prior to dressing
of the wounds. These patients were selected without age
and gender discrimination and all had infected wounds
from various causes. The swabs were streaked and subcul-
tured three times in sterile nutrient agar plates and subse-
quently maintained on agar slants stored at 4°C. The
isolates were characterized and identified using gram
staining, colony characterization, cetrimide agar, gelatin
liquefaction, sodium chloride and mannitol fermentation
tests [18]. Antimicrobial activity test was performed using
the agar well diffusion method of Lovian [19]. Briefly,
sterile Muller Hinton agar plates were flooded with 1 ×
106 cfu/ml concentration of microorganisms. Using a ster-
ile cork borer (7 mm diameter), 6 wells were bored on the
agar and three drops of one of the ME, HF or MF (0.5,
0.25, 0.125, 0.0625, 0.03125 mg/ml in 10% dimethylsul-
foxide (DMSO) placed in the appropriate well. DMSO
(10%) was used as control. The plates were allowed 30
min for diffusion and incubated inverted for 24 h at 37°C.
Microbial sensitivity was determined in triplicate. After
incubation, the diameter of inhibition zone for each well
was measured horizontally and vertically and the mean
obtained. The minimum inhibitory concentration (MIC)
was determined as intercept on the concentration axis of
Concentration vs mean IZD2 plot.
Wound epithelialisation time test
The effect of the extract and fractions on the rate of wound
healing activity was evaluated using wound epithelialisa-
tion time in rats. Adult albino rats (200–280 g) of both
sexes were divided into 4 groups of 6 animals each. Each
group received either 200 or 400 mg/kg of one of the ME,
HF or MF suspended in 3% v/v Tween 85. Control ani-
mals received the vehicle. Each animal was anaesthetized
with subcutaneous injection of lignocaine (2% w/v adren-
aline 1:10 000). An excision wound of about 100 mm2
was created on the inner surface of the right hind leg using
sterile surgical blades. Extract and fractions were adminis-
tered orally to the animals once daily for ten days starting
from the day of wound creation. Wound circumference
was measured daily for the ten days and the period of epi-
thelialisation was calculated as the number of days
required for the scar to fall off leaving no raw wound [20].
Statistical analysis
Results were analyzed using one way analysis of variance
(ANOVA) and expressed as Mean ± SEM. Data was further
subjected to LSD post hoc test and differences between
means accepted significant at P < 0.05.
Results
Extraction and phytochemical analysis
The extraction process yielded 4.08% of the methanol
extract (ME), 0.42% of n-hexane fraction (HF) and 3.56%
of methanol fraction (MF) (Table 1). The methanol
extract (ME) gave positive reactions for alkaloids, sapon-
ins, tannins, flavonoids, resins, steroids, terpenoids and
carbohydrates. The n-hexane fraction (HF) tested positive
for sterols and terpenoids while the methanol fraction
(MF) gave positive reactions for alkaloids, glycosides,
saponins, flavonoids, tannins, resins, steroids and carbo-
hydrates (Table 1).
Acute toxicity and lethality (LD50) test
The acute toxicity testing of the methanol extract (ME) in
mice gave an i.p LD50 of 894 mg/kg (Table 2).
Effect of extract and fractions on bleeding/clotting time 
and coagulation time of whole blood
The extract and fractions significantly (P < 0.05) reduced
bleeding/clotting time in rats. On coagulation of whole
blood, the extract and fractions decreased the coagulation
time of whole rat blood in a dose-dependent manner. In
both tests, the magnitude of activity is of the order:
MF>ME>HF (Table 3).BMC Complementary and Alternative Medicine 2007, 7:24 http://www.biomedcentral.com/1472-6882/7/24
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Effect of extract and fractions on microbial wound 
contaminants
Characterization of the clinical wound isolates estab-
lished their identity as species of Pseudomonas fluorescens
and Staphyloccocus aureus (Table 4). The extract and frac-
tions exhibited varying levels of inhibitory effect on these
bacteria. The methanol fraction (MF) caused the greatest
inhibitory effect against all the organisms followed by ME
with the n-hexane fraction (HF) exhibiting the least activ-
ity (Table 4).
Effect of extract and fractions on wound epithelialisation 
time
The extract and fractions significantly (P < 0.05) reduced
epithelialisation time in rats in a non-dose-related man-
ner. The methanol fraction (MF) caused the highest reduc-
tion while ME and n-hexane fraction (HF) exhibited
comparable levels of reduction (Table 5).
Discussion
Evaluation of the potentials of A. africana in wound care
showed that the leaf extract and fractions exhibited hae-
mostatic, antimicrobial and wound healing activities sug-
gesting that the constituents of the leaves may play a
useful role in wound care. The extract and fractions
arrested bleeding from fresh wounds by reducing bleed-
ing/clotting and whole blood coagulation time which are
important indices of haemostatic activity. In separate
studies elsewhere, A. africana leaf extracts demonstrated
haemostatic activity [8,14]. Haemostasis involves the
spontaneous arrest of bleeding from damaged blood ves-
sels [21] which is important for initiation of tissue repair
processes and prevention of tissue death through haemor-
rhage. The haemostatic process proceeds through a cas-
cade of reactions, which starts with vascular spasm of the
ruptured vessels [22,23], formation of platelet plug
through platelet aggregation, and coagulation of the
blood [22]. Leaf extracts of A. africana have been shown to
increase vascular tone [12] which is a measure of vasocon-
striction and suggestive of the possibility of the leaf
extracts arresting bleeding from fresh wounds through
this mechanism. However, blood clotting and coagula-
tion also involve other mechanisms such as prothrombin
activation with its subsequent conversion to thrombin
and which in turn converts fibrinogen to insoluble fibrin
[22]. The reduction of coagulation time of whole blood by
the leaf extracts is an indication that the extracts may also
interfere with the blood coagulation pathways. Thus, the
Table 1: Phytochemical constituents of extract and fractions
Phytochemical constituents Extract and fractions
ME (4.08%) HF (0.42%) MF (3.56%)
Alkaloids + - +
Glycosides - - +
Saponins + - +
Tannins + - +
Flavonoids + - +
Resins + - +
Sterols + + -
Terpenoids + + -
Carbohydrates + - +
Values in parenthesis are extractive yields. + = Present; - = Absent.
ME = Methanol extract; HF = n-Hexane fraction; MF = Methanol fraction
Table 2: Result of acute toxicity and lethality (LD50) test
Stage of test Dose (mg/kg) Number of death per group









The i.p LD50 was calculated as 894 mg/kg.BMC Complementary and Alternative Medicine 2007, 7:24 http://www.biomedcentral.com/1472-6882/7/24
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haemostatic effect of the extract may derive from accelera-
tion of the coagulation process with the consequent
reduction in clotting time as well as vasoconstriction
which are necessary in limiting blood loss from damaged
vessels.
Wounds provide environments conducive for the growth
of microbial organisms. Usually, microbial contamina-
tions of wounds involve a variety of organisms such as
Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus
faecalis, Escherichia coli, Clostridium perfringens, Clostridium
tetani, Coliform bacilli and enterococcus [24,25]. Evalua-
tion of the effect of the extractives on clinically isolated
microbial contaminants of wounds showed varying levels
of inhibitory activity against species of Pseudomonas and
Staphylococcus. Microbial infection of wounds delays heal-
ing [25,26] and causes a more pronounced acute inflam-
matory reaction [2] which can lead to further tissue injury
and damage. Thus, the antimicrobial activity of the extract
and fractions on these wound isolates may partly contrib-
ute to the wound healing effect by eliminating infection
thus allowing the natural tissue repair processes to start. It
also suggests that the leaf extracts may also play a useful
role in accelerating the healing of old wounds by eradicat-
ing already established infection. The antimicrobial activ-
ity of honey and the essential oil of Melaleuca alternifolia is
believed to underlie their usefulness as alternative therapy
in wound healing [25,27,28].
In addition to inhibiting the growth of these micro-organ-
isms, the extract and fractions effectively reduced the epi-
thelialisation period of experimentally-induced wounds
which is an index of pro-healing activity. The precise
aspect as well as the exact mechanism of wound healing
affected by the extract and fractions is yet to be elucidated.
In the tissue repair process, inflammatory cells promote
the migration and proliferation of endothelial cells, lead-
ing to neovascularisation of connective tissue cells which
synthesize extracellular matrices including collagen, and
of keratinocytes resulting to re-epithelialisation of the
Table 3: Bleeding/clotting and whole rat blood coagulation time
Extract/fraction Concentration (μg/ml) Bleeding/clotting time (s) Coagulation time (s)
ME 10 NT 102.67 ± 31.08
100 31.33 ± 0.67a, b 55.67 ± 8.95
HF 10 NT 115.00 ± 26.50
100 42.00 ± 2.31a, b 64.00 ± 25.53
MF 10 NT 98.33 ± 36.84
100 30.33 ± 3.84a, b 42.67 ± 2.40a
Normal saline 54.00 ± 2.18 48.67 ± 5.20
Control 52.00 ± 0.58 89.33 ± 9.39
a, bP < 0.05 compared to Control and normal saline respectively (ANOVA; LSD post hoc); Values of bleeding and coagulation time shown are Mean ± 
SEM (n = 3); ME = Methanol extract; HF = n-Hexane fraction; MF = Methanol fraction; NT = Not tested.
Table 4: Minimum inhibitory concentration of extract and fractions
Microorganism Minimum inhibitory concentration (MIC) (mg/ml)
ME HF MF
Ps. fluorescens (Isolate 1) 0.125 0.25 0.25
Ps. fluorescens (Isolate 2) - - -
Ps. fluorescens (Isolate 3) 0.25 0.5 0.5
Ps. fluorescens (Isolate 4) 0.125 - 0.5
Ps. fluorescens (Isolate 5) 0.25 0.25 -
Ps. fluorescens (Isolate 6) - 0.25 0.125
Ps. fluorescens (Isolate 7) 0.125 0.5 0.125
Ps. aeruginosa (ATCC 10145) 0.125 - -
Staph. aureus (Isolate 1) 0.5 0.5 0.063
Staph. aureus (ATCC 12600) - - 0.25
Control - - -
Control = 10% Dimethylsulfoxide (DMSO)
ME = Methanol extract; HF = n-Hexane fraction; MF = Methanol fraction - = No activityBMC Complementary and Alternative Medicine 2007, 7:24 http://www.biomedcentral.com/1472-6882/7/24
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wounded tissue [29]. In the wound healing process, colla-
gen formation peaks at day 7 and epithelialisation occurs
in 48 h under optimal conditions [30]. The extent to
which the extractives interact with these processes is not
known to us.
Phytochemical analysis of the extract and fractions indi-
cated the presence of typical plant constituents such as
alkaloids, saponins, sterols, terpenoids, carbohydrates,
glycosides and tannins. These metabolites are usually
responsible for the pharmacological activities of medici-
nal plants. α-pinene, one of the terpenoids in A. africana
leaves, is known to possess anti-inflammatory activity
[31] and may contribute to the wound healing activity by
suppressing inflammatory reactions invoked by the
injured tissues. In addition to this, the documented iden-
tification of the abundant presence of saponins and tan-
nins in the leaves of this plant [14] is implicating for these
constituents in the activities of the leaf extracts, especially
tannins, which have been implicated in the haemostatic
activity of plants where they arrest bleeding from dam-
aged or injured vessels by precipitating proteins to form
vascular plugs. To a reasonable extent, going by the quan-
tified relative presence in the leaves of this plant and doc-
umented role in haemostatic activity, we may safely
assume that the tannins in the extracts partly contribute to
the activity since mechanisms other than vascular plugs
formation are likely involved.
Conclusion
The leaf extract and fractions of A. africana effectively
arrested bleeding from fresh wounds, inhibited microbial
growth of known wound contaminants and accelerated
wound healing process. The results of this study indicate
that extracts of leaves of A. africana have good potentials
for use in wound care and further provide a rationale for
the use of the leaves of this plant in wound management
in traditional medicine practice.
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